Prescribing amoxicillin clavulanate appropriately
In this Audit
Amoxicillin clavulanate is a broad spectrum antibiotic used in primary care in New Zealand. While amoxicillin clavulanate
and other broader spectrum antibiotics (quinolones and cephalosporins) are highly effective, their use should be avoided
when an antibiotic with a narrower spectrum will cover the most likely infective microorganism. Amoxicillin clavulanate
is best reserved for clinical situations where cover for potential polymicrobial infections is required. The over-use of
broad-spectrum antibiotics increases the risk of Clostridium difficile, MRSA and other resistant infections.
In addition, as with many broad spectrum antibiotics, amoxicillin clavulanate is associated with an increased risk of
adverse effects, beyond those commonly seen with other antibiotics, such as cholestatic jaundice, a form of acute liver
Amoxicillin clavulanate is an appropriate first-line antibiotic for a few limited conditions, including:
- Mammalian bites and closed-fist wounds
- Diabetic foot infections
- Acute pyelonephritis*
- Mastitis in males and non-lactating females
* Amoxicillin clavulanate is now considered a second-line option for acute pyelonephritis (first line is co-trimoxazole)
Second-line indications for amoxicillin clavulanate include:
- Epidiymo-orchitis – if UTI pathogens are suspected and there is a contraindication to quinolones (First-line: ciprofloxacin)
- Urinary tract infection in a child – (First-line: cotrimoxazole, Alternative: cefaclor)
- Sinusitis – if antibiotics were indicated and symptoms persist despite treatment with a narrow-spectrum antibiotic
For further information, see:
"Antibiotics Guide, Choices for common infections",
Supplement to BPJ 54 (Jul, 2013).
Recommendations for this audit
Amoxicillin clavulanate should only be used for a limited range of conditions (as above).
All patients that have been prescribed amoxicillin clavulanate in the past year can be audited to see whether the reason
they were prescribed amoxicillin clavulanate, rather than another antibiotic, was valid and appropriate.
Criteria for a positive outcome
The patient received amoxicillin clavulanate and an appropriate indication for the medicine is recorded in their patient
notes or in the PMS
By the end of the second audit cycle, the number of amoxicillin clavulanate prescriptions for which there was an appropriate
indication identified should ideally be over 85%.
Any patient that has received a prescription for amoxicillin clavulanate in the previous 12 months is eligible for this
You will need to have a system in place that allows you to identify eligible patients. Many practices will be able to
identify patients by running a ‘query’ through their PMS system. We suggest you identify all patients in the previous 12
months who have had a prescription for amoxicillin clavulanate
The number of eligible patients will vary according to your practice demographic. If you identify a large number of patients,
take a random sample of 30 patients whose notes you will audit (or the first 30 results returned).
Use the data sheet provided to
record you first and second cycles. In each data set, calculate the number of “positives” by dividing the total number
of patients who received amoxicillin clavulanate, by the number of “Yes” results in the appropriate indication column.
The recording of the indication should be used to help evaluate future practice and identify any areas of amoxicillin
clavulanate prescription that could be improved within the practice.
Identifying opportunities for CQI
The first step to improving medical practice is to identify the criteria where gaps exist between expected and actual
performance and then to decide how to change practice.
Decide on a set of priorities for change and develop an action plan to implement any changes.
It may be useful to consider the following points when developing a plan for action:
Problem solving process
- What is the problem or underlying problem(s).
- Change it to an aim.
- What are the solutions or options?
- What are the barriers?
- How can you overcome them?
- Identifying barriers can provide a basis for change.
- What is achievable – find out what the external pressures on the practice are and discuss ways of dealing with them
in the practice setting.
- Identify the barriers.
- Develop a priority list.
- Choose one or two achievable goals.
- No single strategy or intervention is more effective than another, and sometimes a variety of methods are needed to
bring about lasting change.
- Interventions should be directed at existing barriers or problems, knowledge, skills and attitudes, as well as performance
Monitoring change and progress
It is important to review the action plan against the timeline at regular intervals with the practice team. It may be
helpful to discuss the following questions:
- Is the process working?
- Are the goals for improvement being achieved?
- Are the goals still appropriate?
- Do you need to develop new tools to achieve the goals you have set?
Following the completion of the first cycle, it is recommended that practices complete the first part of the
CQI activity summary sheet.
Undertaking a second cycle
In addition to regular reviews of progress with the practice team, a second audit cycle should be completed in order
to quantify progress on closing the gaps in performance.
It is recommended that the second cycle be completed within 12 months of completing the first cycle. The second cycle
should begin at the data collection stage. Following the completion of the second cycle it is recommended practices complete
the remainder of the CQI activity